FDA Approved: AUSTEDO XR — Supplemental Application (Teva Neuroscience, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AUSTEDO XR (deutetrabenazine) by Teva Neuroscience, expanding the product to include an extended-release formulation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease
• Tardive Dyskinesia

Drugs mentioned

• AUSTEDO XR (deutetrabenazine)

Snippet

SUPPL AP for AUSTEDO XR (DEUTETRABENAZINE)